---
figid: PMC3464940__1866-1955-4-19-2
figlink: /pmc/articles/PMC3464940/figure/F2/
number: Figure 2
caption: Schematic illustration of cellular mechanisms of neurotransmission in the
  mesolimbic dopamine (DA) reward pathway. Shown is a synapse between a ventral tegmental
  area DA neuron axon terminal and a medium spiny neuron (MSN) in the nucleus accumbens
  (NAc) in the ventral striatum. Transmission begins with an action potential that
  arrives to the terminal, inducing synaptic vesicle fusion and release of DA. The
  release of DA into the NAc stimulates various populations of MSNs, whose response
  to the transmitter depends on the types of DA receptors they express. DA stimulation
  of neurons containing D1 or D5 receptors (so-called D1-like receptors) results in
  activation of heterotrimeric Golf/Gs proteins, which activate the enzyme adenylyl
  cyclase, resulting in the synthesis of the second messenger cAMP. In contrast to
  this mechanism, DA stimulation of MSNs that express D2, D3 or D4 (or D2-like receptors)
  activate sheterotrimeric Gi/Go proteins, which inhibit adenylyl cyclase activity
  to decrease cAMP. The level of intracellular cAMP controls the activation of protein
  kinase A, which regulates additional signaling molecules including dopamine- and
  cAMP-regulated neuronal phosphoprotein of 32 kDa (DARPP-32) and the transcription
  factor cAMP response element binding (CREB) protein, both of which can modulate
  gene expression and additional cellular responses. The response to DA is generally
  terminated when DA is removed from the synapse by reuptake via the DA transporter
  (DAT). After reuptake, the transmitter can be repackaged into synaptic vesicles
  or may be degraded by the enzyme monoamine oxidase, resulting in the DA metabolite
  homovanillic acid. In addition, the enzyme catechol-o-methyltransferase (COMT) may
  also control DA levels by breaking down DA to 3-methoxytyramine (3-MT), AC, adenylyl
  cyclase; ATP; adensosine triphosphate; cAMP; cyclic adenosine monophosphate; HVA,
  homovanillic acid; MAO, monoamine oxidase; VTA, ventral tegmental area.
pmcid: PMC3464940
papertitle: 'Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders
  and genetic syndromes: animal models and clinical findings.'
reftext: Gabriel S Dichter, et al. J Neurodev Disord. 2012;4(1):19-19.
pmc_ranked_result_index: '128302'
pathway_score: 0.9310734
filename: 1866-1955-4-19-2.jpg
figtitle: Cellular mechanisms of neurotransmission in the mesolimbic dopamine (DA)
  reward pathway
year: '2012'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3464940__1866-1955-4-19-2.html
  '@type': Dataset
  description: Schematic illustration of cellular mechanisms of neurotransmission
    in the mesolimbic dopamine (DA) reward pathway. Shown is a synapse between a ventral
    tegmental area DA neuron axon terminal and a medium spiny neuron (MSN) in the
    nucleus accumbens (NAc) in the ventral striatum. Transmission begins with an action
    potential that arrives to the terminal, inducing synaptic vesicle fusion and release
    of DA. The release of DA into the NAc stimulates various populations of MSNs,
    whose response to the transmitter depends on the types of DA receptors they express.
    DA stimulation of neurons containing D1 or D5 receptors (so-called D1-like receptors)
    results in activation of heterotrimeric Golf/Gs proteins, which activate the enzyme
    adenylyl cyclase, resulting in the synthesis of the second messenger cAMP. In
    contrast to this mechanism, DA stimulation of MSNs that express D2, D3 or D4 (or
    D2-like receptors) activate sheterotrimeric Gi/Go proteins, which inhibit adenylyl
    cyclase activity to decrease cAMP. The level of intracellular cAMP controls the
    activation of protein kinase A, which regulates additional signaling molecules
    including dopamine- and cAMP-regulated neuronal phosphoprotein of 32 kDa (DARPP-32)
    and the transcription factor cAMP response element binding (CREB) protein, both
    of which can modulate gene expression and additional cellular responses. The response
    to DA is generally terminated when DA is removed from the synapse by reuptake
    via the DA transporter (DAT). After reuptake, the transmitter can be repackaged
    into synaptic vesicles or may be degraded by the enzyme monoamine oxidase, resulting
    in the DA metabolite homovanillic acid. In addition, the enzyme catechol-o-methyltransferase
    (COMT) may also control DA levels by breaking down DA to 3-methoxytyramine (3-MT),
    AC, adenylyl cyclase; ATP; adensosine triphosphate; cAMP; cyclic adenosine monophosphate;
    HVA, homovanillic acid; MAO, monoamine oxidase; VTA, ventral tegmental area.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L3
  - PRKACB
  - CREB3L1
  - ADCY7
  - ADCY8
  - ADCY10
  - GNAZ
  - ADCY4
  - MSN
  - CREB5
  - PPP1R1B
  - ADCY6
  - ATF1
  - CREB3L2
  - ADCY1
  - ADCY9
  - GNAI3
  - GNAI1
  - GNAT1
  - ADCY5
  - PRKAR2B
  - CREM
  - GNAI2
  - GNAT3
  - GNAO1
  - GNAT2
  - CREB1
  - CREB3L4
  - ADCY2
  - SLC6A3
  - AKR1A1
  - PRKAR1A
  - PRKAR2A
  - NLRP1
  - ADCY3
  - PRKACG
  - COMT
  - UBR5
  - AKR1C4
  - ATF2
  - PRKAR1B
  - DLK1
  - PRKACA
  - CREB3
genes:
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAZ
  entrez: '2781'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: MSN
  symbol: MSN
  source: hgnc_symbol
  hgnc_symbol: MSN
  entrez: '4478'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: PKA/DARPP32/CREB
  symbol: DARPP-32
  source: hgnc_alias_symbol
  hgnc_symbol: PPP1R1B
  entrez: '84152'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI3
  entrez: '2773'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI1
  entrez: '2770'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT1
  entrez: '2779'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT3
  entrez: '346562'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAO1
  entrez: '2775'
- word: Gi/Go
  symbol: Gi
  source: bioentities_symbol
  hgnc_symbol: GNAT2
  entrez: '2780'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: DAT
  symbol: DAT
  source: hgnc_alias_symbol
  hgnc_symbol: SLC6A3
  entrez: '6531'
- word: D2,D3,D4
  symbol: DD3
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1A1
  entrez: '10327'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: NAc
  symbol: NAC
  source: hgnc_alias_symbol
  hgnc_symbol: NLRP1
  entrez: '22861'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: COMT
  symbol: COMT
  source: hgnc_symbol
  hgnc_symbol: COMT
  entrez: '1312'
- word: D1,D5
  symbol: DD5
  source: hgnc_alias_symbol
  hgnc_symbol: UBR5
  entrez: '51366'
- word: D2,D3,D4
  symbol: DD4
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1C4
  entrez: '1109'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: D1,D5
  symbol: Delta1
  source: hgnc_alias_symbol
  hgnc_symbol: DLK1
  entrez: '8788'
- word: PKA/DARPP32/CREB
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA/DARPP32/CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
chemicals: []
diseases: []
---
